Title:
TEAD転写因子新規小分子阻害剤
Document Type and Number:
Japanese Patent JP2022525186
Kind Code:
A
Abstract:
本開示の化合物、ならびにそれらの組成物および使用方法。化合物は、TEAD転写因子の活性を阻害し、例えば、がん及び他の疾患を含む、TEAD転写因子の活性に関連する疾患の治療に有用である。【選択図】なし
Inventors:
Mighty, Planab
Abineni, Chandra Sekar
Tarri, Krishna Chaitanya
Panigrahi, Sunil Kumar
U, Shu
Jargmiri, Gopara Krishna
San, Yang
Abineni, Chandra Sekar
Tarri, Krishna Chaitanya
Panigrahi, Sunil Kumar
U, Shu
Jargmiri, Gopara Krishna
San, Yang
Application Number:
JP2021555405A
Publication Date:
May 11, 2022
Filing Date:
March 13, 2020
Export Citation:
Assignee:
The General Hospital Corporation
International Classes:
C07C229/56; A61K31/136; A61K31/196; A61K31/198; A61K31/215; A61K31/245; A61K31/277; A61K31/351; A61K31/357; A61K31/397; A61K31/40; A61K31/401; A61K31/41; A61K31/415; A61K31/416; A61K31/4164; A61K31/4184; A61K31/4196; A61K31/426; A61K31/428; A61K31/44; A61K31/4402; A61K31/4439; A61K31/445; A61K31/4545; A61K31/4704; A61K31/496; A61K31/4965; A61K31/505; A61K31/517; A61K31/519; A61K31/5375; A61K31/63; A61P35/00; A61P35/02; C07C211/50; C07C229/40; C07C229/46; C07C233/57; C07C235/16; C07C237/20; C07C237/24; C07C237/40; C07C255/58; C07C275/40; C07C311/08; C07C311/18; C07C317/36; C07C381/00; C07D205/04; C07D207/16; C07D209/08; C07D211/60; C07D211/62; C07D213/74; C07D213/79; C07D213/80; C07D213/82; C07D215/227; C07D231/14; C07D231/56; C07D233/61; C07D233/64; C07D235/08; C07D235/18; C07D239/28; C07D239/48; C07D239/88; C07D241/20; C07D241/26; C07D249/04; C07D257/04; C07D275/06; C07D277/42; C07D295/12; C07D295/135; C07D309/14; C07D317/32; C07D401/08; C07D401/12; C07D471/04; C07D491/107
Domestic Patent References:
JP2005527529A | 2005-09-15 | |||
JP2018528246A | 2018-09-27 | |||
JP2002249473A | 2002-09-06 | |||
JP2013501785A | 2013-01-17 | |||
JP2007538092A | 2007-12-27 |
Foreign References:
WO2012135641A2 | 2012-10-04 | |||
WO2011002038A1 | 2011-01-06 | |||
WO2015026990A2 | 2015-02-26 | |||
WO2018154118A2 | 2018-08-30 | |||
WO2017158190A1 | 2017-09-21 |
Other References:
STEPANOV, F. N. 他: "Synthesis and biological activity of some derivatives of N-[(1-adamantyl)phenyl]anthranilic acid", PHARMACEUTICAL CHEMISTRY JOURNAL, vol. 5(10), JPN6022051482, 1971, pages 588 - 589, ISSN: 0004939373
YAMAOKA, NAGAHISA 他: "Identification of novel plasminogen activator inhibitor-1 inhibitors with improved oral bioavailabil", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 28(4), JPN6022051480, 2018, pages 809 - 813, ISSN: 0004939375
"PubChem CID 407452", PUBCHEM [ONLINE], JPN6022051479, 26 March 2005 (2005-03-26), pages 1, ISSN: 0004939374
YAMAOKA, NAGAHISA 他: "Identification of novel plasminogen activator inhibitor-1 inhibitors with improved oral bioavailabil", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 28(4), JPN6022051480, 2018, pages 809 - 813, ISSN: 0004939375
"PubChem CID 407452", PUBCHEM [ONLINE], JPN6022051479, 26 March 2005 (2005-03-26), pages 1, ISSN: 0004939374
Attorney, Agent or Firm:
Hiroshi Kobayashi
Norio Omori
Yukiko Uetake
Norio Omori
Yukiko Uetake
Previous Patent: Antibacterial coating
Next Patent: Methods of surface modification of silicone for specific targets and high efficiency binding
Next Patent: Methods of surface modification of silicone for specific targets and high efficiency binding